SMARCA2 and lymphoma: In summary, during lymphocyte differentiation, SMARCA4 and SMARCA2 affect lymphocytic function and the development of related diseases, especially leukemia and lymphoma, by enhancing chromatin accessibility and interacting with various TFs.